Clinical Trials · NCT04050670
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 54
- Start date
- Sep 2019
- Locations
- 1 site, United States
- Primary endpoint
- Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve of Tirzepatide From Time Zero to Infinity (AUC[0-∞])